The Irell & Manella Graduate School of Biological Sciences trains students in a collaborative and diverse environment to apply their talents and creativity to advance understanding in seeking the cures for diseases.
For medical professionals, City of Hope has a long-standing commitment to continuing medical education, sharing advances in cancer research and treatment with the health-care community through conferences and symposia.
Just as City of Hope offers continuing medical education for physicians, we also offer an innovative series of educational programs for other health professionals such as nurses, radiation therapists, pharmacists and cancer researchers.
Recognized worldwide for its innovative approaches to advancing science, City of Hope offers a number of programs and training that serve postdoctoral trainees, medical professionals and City of Hope staff.
Recognized worldwide for its innovative approaches to advancing science, City of Hope offers a number of hands-on administrative and clinical fellowships and residencies.
Jeff Andrews and his wife Heidi were married only three years and raising a two-year-old son when Jeff was diagnosed with cancer, an experience that brought unexpected challenges to their relationship. Now, a year later, the couple has learned new coping strategies through Couples Coping with Cancer Together, a support group sponsored by City of Hope’s Department of Supportive Care Medicine.
When she was just 9 years old, Gina Marchini had to be airlifted to a hospital when her undiagnosed diabetes nearly killed her. This week, the 33-year-old kindergarten teacher from Palmer, Alaska told a national television audience that, after an islet cell transplant performed at City of Hope last year, her body is now producing its own insulin.
Neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., associate professor in the Division of Neurosurgery, at City of Hope, shares what cancer patients can takeaway from President Carter’s cancer journey.
City of Hope researchers have announced game-changing technology to chemically modify antibodies (Abs) so that they can cross cell membranes to disable disease-causing proteins inside cells, a feat long-sought by researchers worldwide. The new technology is expected to lead to never-before-imagined targeted treatments for some of the most intractable diseases.
Grieving for the people we love after they die is a behavior as innate and natural as loving them in life. And while grief is a universal experience, it’s never easy to deal with—especially when a loved one passes after an emotional battle with cancer.